Symposium on drug safety. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. The situation in the United Kingdom.
作者信息
Cahal D A
出版信息
Can Med Assoc J. 1968 Feb 10;98(6):271-5.
Abstract
摘要
相似文献
1
Symposium on drug safety. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. The situation in the United Kingdom.
Can Med Assoc J. 1968 Feb 10;98(6):271-5.
2
Clinical pharmacology in the United Kingdom.
Clin Pharmacol Ther. 1974 Sep;16(3):605-15. doi: 10.1002/cpt1974163part2605.
3
[Pharmacovigilance in the framework of recording and control of drugs in the United Kingdom].
Therapie. 1974 Nov-Dec;29(6):799-804.
4
Adverse drug reactions. A problem for drug regulatory agencies.
Int J Clin Pharmacol. 1973 Apr;7(2):183-9.
5
Communicating adverse drug reactions.
Lancet. 1978 Jan 21;1(8056):133.
6
Crying wolf on drug safety.
Br Med J (Clin Res Ed). 1982 Jan 23;284(6311):219-20.
7
Discussion on control of new drugs.
Practitioner. 1971 Apr;206(234):546-50.
8
Drugs and the Washington climate.
Trans Am Clin Climatol Assoc. 1969;80:196-204.
9
Present attitudes of governmental drug regulatory agencies.
Int J Clin Pharmacol. 1973 Apr;7(2):168-77.
10
Present status of clinical pharmacology and of regulatory requirements for preclinical and clinical evaluation of new drugs in Japan.
Clin Pharmacol Ther. 1974 Sep;16(3):577-84. doi: 10.1002/cpt1974163part2577.
Zotero 插件